BNP Paribas Financial Markets’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.34M | Buy |
|
|||||
|
2025
Q2 | $1.9M | Buy |
|
|||||
|
2025
Q1 | $91.7K | Buy |
|
|||||
|
2024
Q4 | $65.7K | Sell |
|
|||||
|
2024
Q3 | $61.1K | Buy |
|
|||||
|
2024
Q2 | $15.4K | Buy |
|
|||||
|
2024
Q1 | $313 | Sell |
|
|||||
|
2023
Q4 | $11K | Hold |
|
|||||
|
2023
Q3 | $10.1K | Buy |
|
|||||
|
2023
Q2 | $7.95K | Hold |
|
|||||
|
2023
Q1 | $4.87K | Sell |
|
|||||
|
2022
Q4 | $5.5K | Sell |
|
|||||
|
2022
Q3 | $7.85K | Sell |
|
|||||
|
2022
Q2 | $32K | Buy |
|
|||||
|
2022
Q1 | $29.1K | Sell |
|
|||||
|
2021
Q4 | $160K | Sell |
|
|||||
|
2021
Q3 | $225K | Buy |
|
|||||
|
2021
Q2 | $239K | Sell |
|
|||||
|
2021
Q1 | $252K | Buy |
|
|||||
|
2020
Q4 | $57.8K | Sell |
|
|||||
|
2020
Q3 | $85.3K | Buy |
|
|||||
|
2020
Q2 | $154K | Sell |
|
|||||
|
2020
Q1 | $355K | Buy |
|
|||||
|
2019
Q4 | $88.2K | Sell |
|
|||||
|
2019
Q3 | $73.6K | Buy |
|
|||||
|
2019
Q2 | $50K | Sell |
|
|||||
|
2019
Q1 | $153K | Buy |
|
|||||
|
2018
Q4 | $26.4K | Buy |
|
|||||
|
2018
Q3 | $16K | Sell |
|
|||||
|
2018
Q2 | $23.5K | Sell |
|
|||||
|
2018
Q1 | $90.4K | Buy |
|
|||||
|
2017
Q4 | $131K | Buy |
|
|||||
|
2017
Q3 | $85.2K | Sell |
|
|||||
|
2017
Q2 | $65.9K | Buy |
|
|||||
|
2017
Q1 | $543 | Sell |
|
|||||
|
2016
Q4 | $6.27K | Sell |
|
|||||
|
2016
Q3 | $22.8K | Buy |
|
|||||
|
2016
Q2 | $10K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $65.2K | Sell |
|
|||||
|
2015
Q3 | $48.9K | Buy |
|
|||||
|
2015
Q2 | $20.9K | Buy |
|
|||||
|
2015
Q1 | $2.03K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $13K | Buy |
|